title: trans-Fatty acids, insulin resistance/diabetes, and cardiovascular disease risk: should policy decisions be based on observational cohort studies, or should we be waiting for results from randomized placebo-controlled trials?
authors.forename: Konstantinos N
authors.initials: KN
authors.lastname: Aronis
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Joseph
authors.forename: George L
authors.initials: GL
authors.lastname: Blackburn
authors.forename: Christos
authors.initials: C
authors.lastname: Mantzoros
mesh_terms: D002318:Cardiovascular Diseases / Q000178:diet therapy / Q000209:etiology*; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000178:diet therapy / Q000209:etiology*; D004042:Dietary Fats, Unsaturated / Q000009:adverse effects*; D005260:Female; D006291:Health Policy; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D016032:Randomized Controlled Trials as Topic; D044242:Trans Fatty Acids / Q000009:adverse effects*
chemical_list: D004042:Dietary Fats, Unsaturated; D044242:Trans Fatty Acids